Aurinia Pharmaceuticals (AUPH) News Today → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free AUPH Stock Alerts $5.30 -0.09 (-1.67%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5 at 11:53 AM | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Purchased by Armistice Capital LLCArmistice Capital LLC increased its holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Free Report) (TSE:AUP) by 57.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,536,000 shares of the biotechnolJune 5 at 6:00 AM | businesswire.comAurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024June 4, 2024 | marketbeat.comCampbell & CO Investment Adviser LLC Invests $2.09 Million in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)Campbell & CO Investment Adviser LLC acquired a new position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Free Report) (TSE:AUP) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 232,411 shares of tMay 31, 2024 | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Sees Significant Increase in Short InterestAurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Get Free Report) (TSE:AUP) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 11,530,000 shares, an increase of 12.4% from the April 30th total of 10,260,000 shares. Based on an average trading volume of 1,530,000 shares, the days-to-cover ratio is currently 7.5 days.May 30, 2024 | businesswire.comAurinia Will Attend 2024 Jefferies Global Healthcare ConferenceMay 26, 2024 | finance.yahoo.comShareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 64%, as stock drops 9.5% this past weekMay 16, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 6.2%Aurinia Pharmaceuticals (NASDAQ:AUPH) Trading Up 6.2%May 15, 2024 | marketbeat.comShort Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Declines By 9.9%Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Get Free Report) (TSE:AUP) was the recipient of a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 10,260,000 shares, a decline of 9.9% from the April 15th total of 11,390,000 shares. Based on an average daily volume of 2,070,000 shares, the short-interest ratio is presently 5.0 days. Currently, 8.1% of the shares of the company are sold short.May 15, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Pass Below Two Hundred Day Moving Average of $6.98Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Crosses Below Two Hundred Day Moving Average of $6.98May 14, 2024 | finance.yahoo.comAnalysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024May 14, 2024 | businesswire.comAnalysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024May 13, 2024 | stocknews.comTop 4 Pharma Stocks to Consider This MonthMay 9, 2024 | finance.yahoo.comAurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024May 7, 2024 | businesswire.comAurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder ValueMay 7, 2024 | businesswire.comAurinia Will Attend 2024 RBC Capital Markets Global Healthcare ConferenceMay 3, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Stock Rating Upgraded by StockNews.comStockNews.com upgraded shares of Aurinia Pharmaceuticals from a "hold" rating to a "buy" rating in a research note on Friday.May 2, 2024 | seekingalpha.comAurinia Pharmaceuticals Inc. (AUPH) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Gap Up to $5.20Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Gap Up to $5.20May 2, 2024 | markets.businessinsider.comLeerink Partners Keeps Their Buy Rating on Aurinia Pharmaceuticals (AUPH)May 2, 2024 | businesswire.comAurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational ResultsMay 1, 2024 | markets.businessinsider.comAurinia Pharmaceuticals is about to announce earnings — here's what Wall Street expectsMay 1, 2024 | businesswire.comAurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness MonthApril 30, 2024 | seekingalpha.comAurinia: Updated Lupkynis Label Should Keep Sales Growth Momentum GoingApril 30, 2024 | businesswire.comThe U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical ProgramApril 29, 2024 | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 6.9% in AprilAurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Get Free Report) (TSE:AUP) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 11,390,000 shares, a decline of 6.9% from the March 31st total of 12,240,000 shares. Currently, 8.9% of the company's stock are short sold. Based on an average daily trading volume, of 2,060,000 shares, the short-interest ratio is currently 5.5 days.April 18, 2024 | seekingalpha.comAurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024April 18, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 52-Week Low at $4.82Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 12-Month Low at $4.82April 16, 2024 | businesswire.comUPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 15, 2024 | businesswire.comAurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024April 14, 2024 | marketbeat.comShort Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Increases By 14.9%Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Get Free Report) (TSE:AUP) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 12,240,000 shares, an increase of 14.9% from the March 15th total of 10,650,000 shares. Based on an average trading volume of 2,340,000 shares, the days-to-cover ratio is currently 5.2 days. Approximately 9.6% of the company's stock are sold short.April 9, 2024 | businesswire.comAurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 9, 2024 | sg.finance.yahoo.comBRIEF-Soilbuild Construction Says Group Awarded New ContractsApril 7, 2024 | finance.yahoo.comWhen Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?April 1, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 4.6%Aurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 4.6%March 31, 2024 | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 12.0% in MarchAurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Get Free Report) (TSE:AUP) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 10,650,000 shares, a decrease of 12.0% from the February 29th total of 12,100,000 shares. Based on an average daily trading volume, of 2,360,000 shares, the short-interest ratio is presently 4.5 days. Currently, 8.3% of the shares of the company are sold short.March 26, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month Low at $4.94Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 12-Month Low at $4.94March 19, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month Low at $4.96Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year Low at $4.96March 17, 2024 | finance.yahoo.com11 Oversold Biotech Stocks To Buy Right NowMarch 14, 2024 | finance.yahoo.comAUPH Mar 2024 3.000 callMarch 14, 2024 | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Sees Large Decrease in Short InterestAurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Get Free Report) (TSE:AUP) saw a large drop in short interest in the month of February. As of February 29th, there was short interest totalling 12,100,000 shares, a drop of 28.2% from the February 14th total of 16,850,000 shares. Currently, 9.5% of the shares of the stock are short sold. Based on an average daily volume of 2,470,000 shares, the days-to-cover ratio is currently 4.9 days.March 11, 2024 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 1-Year Low at $5.34Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month Low at $5.34March 11, 2024 | marketbeat.comTrexquant Investment LP Has $423,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)Trexquant Investment LP trimmed its stake in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Free Report) (TSE:AUP) by 83.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 54,403 shares of the biMarch 8, 2024 | finance.yahoo.comWe're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash BurnMarch 5, 2024 | seekingalpha.comAurinia Pharma: Cheaper Now, But Buyout Hopes DashedMarch 3, 2024 | marketbeat.comShort Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Drops By 9.1%Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Get Free Report) (TSE:AUP) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 16,850,000 shares, a decline of 9.1% from the January 31st total of 18,530,000 shares. Based on an average daily volume of 2,520,000 shares, the days-to-cover ratio is currently 6.7 days. Currently, 13.2% of the company's stock are short sold.March 1, 2024 | markets.businessinsider.comAurinia Pharmaceuticals: Strong Buy Rating Amidst Share Repurchase and Promising LUPKYNIS ProspectsMarch 1, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Aurinia Pharmaceuticals (NASDAQ:AUPH)HC Wainwright reissued a "buy" rating and issued a $13.00 price objective on shares of Aurinia Pharmaceuticals in a research report on Friday.February 29, 2024 | marketbeat.comCantor Fitzgerald Comments on Aurinia Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:AUPH)Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH - Free Report) (TSE:AUP) - Equities research analysts at Cantor Fitzgerald dropped their FY2024 earnings per share (EPS) estimates for shares of Aurinia Pharmaceuticals in a research note issued on Monday, February 26th. Cantor Fitzgerald analyst O. BrayeFebruary 29, 2024 | finance.yahoo.comAurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase ProgramFebruary 28, 2024 | investing.comAurinia Pharmaceuticals Inc (AUPH) Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter. Email Address The new masters of energy (Ad)According to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune. Click here to get all the details. AUPH Media Mentions By Week AUPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUPH News Sentiment▼1.310.73▲Average Medical News Sentiment AUPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUPH Articles This Week▼32▲AUPH Articles Average Week Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CYRX News IGMS News YMAB News AMRN News ARWR News XENE News IDYA News FOLD News PTCT News MOR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUPH) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored